Esther B. Sadler-Williams

Esther is currently Global Director, Strategic Alliance Development and Innovation for Catalent Pharma Solutions

Catalent is a clinical solutions provider with a broad range of expert devices that drive more efficient development timelines to help clients bring more compounds and better products to the market faster. Catalent acquired Aptuit CTS in February 2012, a company which had previously acquired Almedica where Esther was Director of Client Development having been a founder member of the then 10 year old European facility. (Almedica provided contract services for clinical supplies including packaging, labelling and distribution). So Esther has worked for 3 different companies for over 19 years without moving offices!

As a pharmacist, Esther has had over 30 years experience in various pharmaceutical fields including 5 years with Sanofi Winthrop where she was Head of Research Services during which time she managed groups of CRA.’s medical writers and information/adverse event surveillance specialists. Previous roles include Principal Pharmacist with the Regional Drug Information Service at St Mary’s Hospital in Manchester, and Pharmacy Manager with Boots the Chemist.

Esther is also a past Chair of ISPE’s EU Investigational Products COP and has been a participant on a number of ISPE task teams as well as a lead author for the ISPE guidance document on NIMPs.

Related Articles

Identifying Global Themes in Clinical Study Participants’
Features
Identifying Global Themes in Clinical Study Participants’

This article examines patient preferences in one facet of clinical research: the experience related to the use of investigational medicinal products (IMPs). As patients have become more involved and informed in their healthcare choices, the “voice of the patient” has been increasingly incorporated into the drug development process. Given that the success of a clinical study relies on the...